---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-005773"
form_type: "8-K"
ticker: "CBDW"
cik: "0001877461"
company_name: "1606 CORP."
filed_at: "2024-09-17T23:59:59+00:00"
generated_at: "2026-05-31T04:22:19.521739+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# 1606 Corp. signs LOI for strategic stake in AI drug-discovery firm Adnexus Biotechnologies

## Summary
- Signed LOI to acquire a strategic stake in Adnexus Biotechnologies; no deal value disclosed.
- Adnexus operates SUTRA AI platform for infectious/neurological disease drug discovery.
- SUTRA platform includes data on 19 viruses, 8M molecules, and human microbiome samples.
- Transaction subject to due diligence and standard conditions; no expected close date given.
- Both CEOs expressed optimism about the partnership advancing AI-driven drug development.

## SEC filing metadata
- accession: 0001477932-24-005773
- form_type: 8-K
- ticker: CBDW
- cik: 0001877461
- company_name: 1606 CORP.
- filed_at: 2024-09-17T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1877461/000147793224005773/0001477932-24-005773-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1877461/000147793224005773/cbdw_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-005773
- JSON: https://secwatch.observer/filing/0001477932-24-005773.json
- Plain text: https://secwatch.observer/filing/0001477932-24-005773.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.